Browse by Uncontrolled Keywords
Number of items: 6.
2011
Arjyal, A;
Basnyat, B;
Koirala, S;
Karkey, A;
Dongol, S;
Agrawaal, KK;
Shakya, N;
Shrestha, K;
Sharma, M;
Lama, S;
+7 more...
Khatri, NS;
Shrestha, U;
Campbell, JI;
Baker, S;
Farrar, J;
Wolbers, M;
Dolecek, C;
(2011)
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.
The Lancet infectious diseases, 11 (6).
pp. 445-454.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(11)70089-5
2010
Boku, N;
Lockwood, DN;
Balagon, MV;
Pardillo, FE;
Maghanoy, AA;
Mallari, IB;
Cross, H;
(2010)
Impacts of the diagnosis of leprosy and of visible impairments amongst people affected by leprosy in Cebu, the Philippines.
Leprosy review, 81 (2).
pp. 111-20.
ISSN 0305-7518
https://researchonline.lshtm.ac.uk/id/eprint/2933
Singh, SP;
Hasker, E;
Picado, A;
Gidwani, K;
Malaviya, P;
Singh, RP;
Boelaert, M;
Sundar, S;
(2010)
Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals.
Tropical medicine & international health, 15.
pp. 29-35.
ISSN 1360-2276
DOI: https://doi.org/10.1111/j.1365-3156.2010.02515.x
Full text not available from this repository.
2007
Rijal, S;
Yardley, V;
Chappuis, F;
Decuypere, S;
Khanal, B;
Singh, R;
Boelaert, M;
de Doncker, S;
Croft, S;
Dujardin, JC;
(2007)
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?
Microbes and infection / Institut Pasteur, 9 (4).
pp. 529-535.
ISSN 1286-4579
DOI: https://doi.org/10.1016/j.micinf.2007.01.009
Full text not available from this repository.
2006
Jadoon, MZ;
Dineen, B;
Bourne, RRA;
Shah, SP;
Khan, MA;
Johnson, GJ;
Gilbert, CE;
Khan, MD;
(2006)
Prevalence of blindness and visual impairment in Pakistan: The Pakistan National Blindness and Visual Impairment Survey.
Investigative ophthalmology & visual science, 47 (11).
pp. 4749-4755.
ISSN 0146-0404
DOI: https://doi.org/10.1167/iovs.06-0374
Sinanovic, E;
Kumaranayake, L;
(2006)
Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
Tropical medicine & international health, 11 (9).
pp. 1466-1474.
ISSN 1360-2276
DOI: https://doi.org/10.1111/j.1365-3156.2006.01686.x
Full text not available from this repository.